What do PAs need to know about prescription drug monitoring programs?

被引：1

作者：

Mospan, Geoffrey A. ^{[1
]}

Lucas, Austin ^{[2
]}

机构：

[1] Wingate Univ, Sch Pharm, Pharm Pharm Law & Internal Med, Wingate, NC 28174 USA

[2] Wingate Univ, Sch Pharm, Wingate, NC USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2017年 / 30卷 / 07期

关键词：

prescription drug monitoring programs; opioid epidemic; opioids; controlled substances; abuse; misuse; UNITED-STATES; IMPACT;

D O I：

10.1097/01.JAA.0000520545.53946.82

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As controlled-substance abuse continues to increase in the United States, clinicians find themselves on the front lines of this epidemic. State-operated prescription drug monitoring programs are a valuable resource that prescribers can use to see patients' controlled substance history. Despite some limitations, these programs have been shown to be an effective method in reducing overdose deaths and the supply of controlled substances in the community.

引用

页码：11 / 12

页数：2